{"rows":[{"id":5948,"title":"EFFICACY AND SAFETY OF PSILOCYBIN IN TREATMENT-RESISTANT DEPRESSION: A REVIEW","authors":"Gawin Mateusz, Koziara Emilia, Gadzina Mateusz, Gawlak Julia, Krzesimir Kuświk Maciej, Tarnawska Zofia, Figiel Karolina, Sontag Wojciech, Zawisza Mateusz, Golec Aleksandra","journal":"International Journal of Innovative Technologies in Social Science","publication_date":"2026-09-21","publication_year":2026,"doi":"10.31435/ijitss.3(51).2026.6573","pubmed_id":null,"openalex_id":"https://openalex.org/W7213945218","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6573","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-09-22 01:20:19","last_checked":"2026-09-28 01:20:29","bibtex":null,"source_record_id":"DOI:10.31435/ijitss.3(51).2026.6573","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6573","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.31435/ijitss.3(51).2026.6573","source_url":"https://doi.org/10.31435/ijitss.3(51).2026.6573","doi":"10.31435/ijitss.3(51).2026.6573","pmid":"","publication_date":"2026-09-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5894,"title":"Oregon’s State-Regulated Psilocybin Services: Early Real-World Safety Signals","authors":"Jason Luoma, Christina Chwyl, Dan Des Jarlais, Christopher Stauffer, Ximena Levander, Ryan Cook, Adie Wilson-Poe, Dennis McCarty, Philip Korthuis","journal":"PsyArXiv","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1177/02698811261481171","pubmed_id":"42665360","openalex_id":"https://openalex.org/W7204528136","source_url":"https://osf.io/preprints/psyarxiv/gauby_v1","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"PsyArXiv","publication_status":"preprint","date_added":"2026-08-30 01:20:04","last_checked":"2026-10-08 01:24:55","bibtex":null,"source_record_id":"PMID:42665360","abstract_available":true,"abstract_source":"PsyArXiv","abstract_source_url":"https://osf.io/preprints/psyarxiv/gauby_v1","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PsyArXiv","source_record_id":"PMID:42665360","source_url":"https://osf.io/preprints/psyarxiv/gauby_v1","doi":"10.1177/02698811261481171","pmid":"42665360","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5860,"title":"Investigating the Effects of Psilocybin on Cognitive Flexibility in Touchscreen and Naturalistic Variations of the Probabilistic Reversal Learning Task","authors":"Anderson, D.; Maillot, N.; Thomas, C. W.; Golden, C. T.; Gilmour, G.; Robinson, E. S.","journal":"bioRxiv","publication_date":"2026-08-12","publication_year":2026,"doi":"10.64898/2026.08.06.743309","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.08.06.743309","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Aging","study_type":"Other","source_name":"bioRxiv","publication_status":"preprint","date_added":"2026-08-13 01:24:42","last_checked":"2026-08-19 01:22:49","bibtex":null,"source_record_id":"DOI:10.64898/2026.08.06.743309","abstract_available":true,"abstract_source":"bioRxiv","abstract_source_url":"https://doi.org/10.64898/2026.08.06.743309","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"bioRxiv","source_record_id":"DOI:10.64898/2026.08.06.743309","source_url":"https://doi.org/10.64898/2026.08.06.743309","doi":"10.64898/2026.08.06.743309","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5810,"title":"Differential effects of psychedelics and classical antidepressants on TrkB dimerization and neurotrophic signalling","authors":"Paula Pastor Muñoz","journal":"Työväentutkimus Vuosikirja","publication_date":"2024-01-01","publication_year":2024,"doi":null,"pubmed_id":null,"openalex_id":"https://openalex.org/W7197990038","source_url":"http://hdl.handle.net/10138/577777","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-09 08:25:32","last_checked":"2026-08-09 08:25:32","bibtex":null,"source_record_id":"http://hdl.handle.net/10138/577777","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"http://hdl.handle.net/10138/577777","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"http://hdl.handle.net/10138/577777","source_url":"http://hdl.handle.net/10138/577777","doi":"","pmid":"","publication_date":"2024-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5790,"title":"PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW","authors":"Łoś Aleksandra, Szkodziński Kacper, Jakubczyk Inga, Maternia Jagoda, Majowicz-Czaszyńska Karolina, Pempuś Wiktoria, Król Nikola, Tomaszek Barbara, Blok Aleksandra, Wiater Dominik, Płodzień Gabriela","journal":"International Journal of Innovative Technologies in Social Science","publication_date":"2026-06-24","publication_year":2026,"doi":"10.31435/ijitss.2(50).2026.5755","pubmed_id":null,"openalex_id":"https://openalex.org/W7168266726","source_url":"https://doi.org/10.31435/ijitss.2(50).2026.5755","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Review Article,Treatment-Resistant Depression,Safety","study_type":"Review Article","source_name":"Crossref","publication_status":"published","date_added":"2026-08-09 08:25:05","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"DOI:10.31435/ijitss.2(50).2026.5755","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.31435/ijitss.2(50).2026.5755","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.31435/ijitss.2(50).2026.5755","source_url":"https://doi.org/10.31435/ijitss.2(50).2026.5755","doi":"10.31435/ijitss.2(50).2026.5755","pmid":"","publication_date":"2026-06-24","importer_version":"2.1.3","text_redistributed":false}},{"id":4845,"title":"Psychedelics Legislation Gains Momentum","authors":"Terri D’Arrigo","journal":"Psychiatric News","publication_date":"2023-02-16","publication_year":2023,"doi":"10.1176/appi.pn.2023.03.3.4","pubmed_id":null,"openalex_id":"https://openalex.org/W4321017755","source_url":"https://doi.org/10.1176/appi.pn.2023.03.3.4","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Safety,Drug Interactions","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:46","last_checked":"2026-08-09 08:25:37","bibtex":null,"source_record_id":"DOI:10.1176/appi.pn.2023.03.3.4","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1176/appi.pn.2023.03.3.4","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1176/appi.pn.2023.03.3.4","source_url":"https://doi.org/10.1176/appi.pn.2023.03.3.4","doi":"10.1176/appi.pn.2023.03.3.4","pmid":"","publication_date":"2023-02-16","importer_version":"2.1.3","text_redistributed":false}},{"id":4623,"title":"Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens","authors":"Shunichiro Ikeda, Toshihiko Kinoshita","journal":"Psychiatry and Clinical Neurosciences Reports","publication_date":"2024-05-16","publication_year":2024,"doi":"10.1002/pcn5.196","pubmed_id":null,"openalex_id":"https://openalex.org/W4397013596","source_url":"https://doi.org/10.1002/pcn5.196","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:29","bibtex":null,"source_record_id":"DOI:10.1002/pcn5.196","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1002/pcn5.196","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/pcn5.196","source_url":"https://doi.org/10.1002/pcn5.196","doi":"10.1002/pcn5.196","pmid":"","publication_date":"2024-05-16","importer_version":"2.1.3","text_redistributed":false}},{"id":3662,"title":"Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms","authors":"Centre Hospitalier Universitaire de Nīmes","journal":"ClinicalTrials.gov","publication_date":"2026-07-01","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07638553","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Safety","study_type":"Other","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-09 10:12:45","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07638553","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07638553","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07638553","source_url":"https://clinicaltrials.gov/study/NCT07638553","doi":"","pmid":"","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3659,"title":"Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression","authors":"University of Zurich","journal":"ClinicalTrials.gov","publication_date":"2022-04-29","publication_year":2022,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT03715127","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Resilience,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-09 10:12:43","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT03715127","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT03715127","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT03715127","source_url":"https://clinicaltrials.gov/study/NCT03715127","doi":"","pmid":"","publication_date":"2022-04-29","importer_version":"2.1.3","text_redistributed":false}},{"id":2792,"title":"Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.","authors":"Eivindvik K, Rasmussen KE, Sund RB","journal":"Acta pharmaceutica Nordica","publication_date":"1989-01-01","publication_year":1989,"doi":null,"pubmed_id":"2610906","openalex_id":"https://openalex.org/W2407151076","source_url":"https://pubmed.ncbi.nlm.nih.gov/2610906/","substance_tags":"psilocybin,psilocin","topic_tags":"Pharmacology,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:34:29","bibtex":null,"source_record_id":"PMID:2610906","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/2610906/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:2610906","source_url":"https://pubmed.ncbi.nlm.nih.gov/2610906/","doi":"","pmid":"2610906","publication_date":"1989-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2501,"title":"The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.","authors":"Sweat NW, Bates LW, Hendricks PS","journal":"Journal of psychoactive drugs","publication_date":"2016-01-01","publication_year":2016,"doi":"10.1080/02791072.2016.1234090","pubmed_id":"27719438","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/27719438/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Creativity,Mystical Experience,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:27","bibtex":null,"source_record_id":"PMID:27719438","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/27719438/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:27719438","source_url":"https://pubmed.ncbi.nlm.nih.gov/27719438/","doi":"10.1080/02791072.2016.1234090","pmid":"27719438","publication_date":"2016-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2175,"title":"Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.","authors":"Dos Santos RG, Hallak JE, Baker G, Dursun S","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2021-04-01","publication_year":2021,"doi":"10.1177/0269881120986422","pubmed_id":"33740877","openalex_id":"https://openalex.org/W3137933781","source_url":"https://pubmed.ncbi.nlm.nih.gov/33740877/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Receptor Pharmacology,Safety,Adverse Events","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:23","bibtex":null,"source_record_id":"PMID:33740877","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33740877/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33740877","source_url":"https://pubmed.ncbi.nlm.nih.gov/33740877/","doi":"10.1177/0269881120986422","pmid":"33740877","publication_date":"2021-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1746,"title":"Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.","authors":"Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H","journal":"Pharmacopsychiatry","publication_date":"2022-07-01","publication_year":2022,"doi":"10.1055/a-1714-9097","pubmed_id":"35045580","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/35045580/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:19","bibtex":null,"source_record_id":"PMID:35045580","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35045580/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35045580","source_url":"https://pubmed.ncbi.nlm.nih.gov/35045580/","doi":"10.1055/a-1714-9097","pmid":"35045580","publication_date":"2022-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1324,"title":"Potential use of psilocybin drugs in the treatment of depression.","authors":"Śladowska K, Kawalec P, Brzostek T, Pilc A","journal":"Expert opinion on emerging drugs","publication_date":"2023-12-01","publication_year":2023,"doi":"10.1080/14728214.2023.2264180","pubmed_id":"37817501","openalex_id":"https://openalex.org/W4387516067","source_url":"https://pubmed.ncbi.nlm.nih.gov/37817501/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:12","bibtex":null,"source_record_id":"PMID:37817501","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37817501/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37817501","source_url":"https://pubmed.ncbi.nlm.nih.gov/37817501/","doi":"10.1080/14728214.2023.2264180","pmid":"37817501","publication_date":"2023-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1233,"title":"Effects of DMT on mental health outcomes in healthy volunteers.","authors":"Timmermann C, Zeifman RJ, Erritzoe D, Nutt DJ, Carhart-Harris RL","journal":"Scientific reports","publication_date":"2024-02-07","publication_year":2024,"doi":"10.1038/s41598-024-53363-y","pubmed_id":"38326357","openalex_id":"https://openalex.org/W4391610480","source_url":"https://pubmed.ncbi.nlm.nih.gov/38326357/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Wellbeing,Personality Change,Observational Study,Healthy Volunteers","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:10","bibtex":null,"source_record_id":"PMID:38326357","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38326357/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38326357","source_url":"https://pubmed.ncbi.nlm.nih.gov/38326357/","doi":"10.1038/s41598-024-53363-y","pmid":"38326357","publication_date":"2024-02-07","importer_version":"2.1.3","text_redistributed":false}},{"id":1211,"title":"Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry","authors":"Wood Madeleine E, Brown Glenna J, Karschner Erin L, Seither Joshua Z, Brown Jordan T, Knittel Jessica L, Walterscheid Jeffrey P","journal":"Journal of Analytical Toxicology","publication_date":"2024-03-01","publication_year":2024,"doi":"10.1093/jat/bkae002","pubmed_id":"38287693","openalex_id":"https://openalex.org/W4391462932","source_url":"https://doi.org/10.1093/jat/bkae002","substance_tags":"psilocin","topic_tags":"Safety,Toxicity","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:38287693","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1093/jat/bkae002","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:38287693","source_url":"https://doi.org/10.1093/jat/bkae002","doi":"10.1093/jat/bkae002","pmid":"38287693","publication_date":"2024-03-01","importer_version":"2.1.3","text_redistributed":false}},{"id":462,"title":"Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View.","authors":"Lashgari NA, Khalaji M, Rana P, Badrabadi F, Rahnama M, Nasoori H, Momeni Roudsari N, Khosravi Nia MM, Shafaroodi H","journal":"Molecular neurobiology","publication_date":"2025-11-01","publication_year":2025,"doi":"10.1007/s12035-025-05097-9","pubmed_id":"40461729","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40461729/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Review Article,Animal Study,In Vitro Study,Inflammation","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:40461729","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40461729/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40461729","source_url":"https://pubmed.ncbi.nlm.nih.gov/40461729/","doi":"10.1007/s12035-025-05097-9","pmid":"40461729","publication_date":"2025-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":215,"title":"Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors","authors":"Mäki-Marttunen Verónica","journal":"Communications Biology","publication_date":"2026-03-26","publication_year":2026,"doi":"10.1038/s42003-026-09912-4","pubmed_id":"41882058","openalex_id":"https://openalex.org/W7140297251","source_url":"https://doi.org/10.1038/s42003-026-09912-4","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:48","bibtex":null,"source_record_id":"PMID:41882058","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1038/s42003-026-09912-4","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:41882058","source_url":"https://doi.org/10.1038/s42003-026-09912-4","doi":"10.1038/s42003-026-09912-4","pmid":"41882058","publication_date":"2026-03-26","importer_version":"2.1.3","text_redistributed":false}}],"total":18,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":"FASTer","author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}